CD30 CAR-T in the Treatment of CD30 Positive Lymphoma

Conditions

• Lymphoma
• B Cell Lymphoma
• CD30+ Peripheral T-cell Lymphoma

Interventions

• DRUG: chimeric antigen receptor gene modified T cells

Sponsor

Shandong Qilu Cell Therapy Engineering Technology Co., Ltd

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]